References
- DeGroot L J, Quilans J. The causes of auto-immune thyroid disease. Endocrine Review 1989; 10: 534
- Bottazzo G F, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R. Organ specific autoimmunity, a 1986 overview. Immunol Rev 1986; 94: 137
- Todd 1, Pujol-Borrell R, Hammond L, Bottazzo G F, Feldman M. Interfcron gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985; 61: 265
- Schwartz BD. The human major histocompatibility HLA-complex. Basic and Clinical Immunology, DP Stites, JD Stobo, JV Wells. Appleton & Lange. 1987; 57–58
- Canonica G W, Cania M, Bagnasco M, Cosulik M E, Giordano G, Moretta L. Proliferation of T8 positive cytolylic T lymphocytes in response to thyroglobulin in human autoimmune thyroiditis. Analysis of cell interactions and culture requirements. Clin Immunol Immunopathol 1985; 36: 40
- MacKenzie W A, Davies TF. An intrathyroid T cell clone specifically cytotoxic for human thyroid cells. Immunology 1987; 61: 101
- Herbeman R B, Djeu J Y, Kaz D H, Ortaldo J R, Ricardi C, Bonnard G D, Holden R, Faguani R, Santoni A, Puccetti P. Natural killer cells, characteristics and regulation of activity. Immunol Rev 1979; 44: 43
- Kasse K, Ljunggnen H G, Piontek G, Kiessling R. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy. Nature 1986; 319: 675
- Harel-Bellan A, Quillet A, Marchial C, DeMans R, Turoz T, Fradelizi D. NK susceptibility of human cells may be regulated by genes in the HLA region of chromosome G. Proc Natl Acad Sci USA 1986; 83: 5688
- Handgretinger R, Kimmig A, Lang P, Daurer B, Kuci S, Bruchelt G, Treuner J, Nietdammer D. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells. Nat Immun Cell Growth Regul 1989; 8: 189
- Kraiem Z, Glaser B, Pauker J, Sadeh O, Sheinfeld M. Bioassay of thyroid stimulating immunoglobulin in cryopreserved human thyroid cells. Clin Chem 1988; 34: 244
- Sugawara S, Abo T, Itah H, Kumagai K. Analysis of mechanisms by which NK cells acquire increased cytotoxicity against class I MHC-eliminated targets. Cellul Immunol 1989; 119: 304
- Morimoto C, Letuin N L, Boyd A W, Hagen M, Brown H M, Kosnacki M M, Schlossman SP. The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985; 134: 3762
- Kotani H, Mitsuya H, Jarrett R F, Yenokida G G, James S P, Strober W. An autoreactive T cell clone that can be activated to provide both helper and suppressor function. J Immunol 1986; 136: 1951
- Benson E M, Giorgi J V, Dvorak A M, Galli S J, Russel PS. Cloned anomalous killer cells derived from allogeneic mixed leucocyte culture. Cell Immunol 1987; 107: 201
- Kraiem Z, Sobel E, Sadeh O, Kinarty A, Lahat N. Effects of y-IFN on DR antigen expression, growth and T3 secretion, iodide uptake and c-AMP accumulation in cultured human thyroid cells. J Clin Metab Endocrinol, in press
- Gopas J, Rager-Zisman B, Bar-Eli M, Hammerling GJ, Segal S. The relationship between MHC antigen expression and metastasis. Advances in Cancer Res 1989; 53: 89
- Labo P I, Spencer CE. Use of anti HLA antibodies to mask MHC gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells. J Clin Invest 1989; 83: 278
- Allison J, Campbell I L, Moraham G, Mandel T F, Harrison L C, Miller J FAP. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature 1988; 333: 529
- Hosai K, Kitur D S, Edidin M. Modulation of HLA antigens in response to the binding of epidermal growth factor by A431 cells. FEBS Lett 1988; 231: 371
- Newell M K, Justement L B, Miles C R, Freed TH. Biochemical characterization of proteins that co-purify with class II antigens of the murine MHC. J Immunol 1988; 140: 1930
- Feltkamp C A, Spiele H, Roos A. Interaction of plasma membrane-associated filaments and H-2 histocompatibility antigens before and after induced patching and capping. J Cell Sci 1987; 88: 313